Member Info for Stout

Selling price 2.75

Price moving - time to BUY

Your purchase is showing on the other IMM

Offering over 17p to sell

*************+1bhkjk_ebifimddk

Telegram account

Being offered 8.20 to sell

Buy the dip but, Fundraising offer carrying 1 warrant is very tasty IMO!

Nice start for the day! lets see what we close at!

Interesting meeting to come at 11.00pm today!

Nice quote & info from ‘The mail on Sunday’!

Shareholder update due 11/8

Meeting at 10.00am BST

Meeting webinar

Can’t wait!

Buy now! DYOR IMO

Facts or Fiction! DYOR

"At an operational level, we have maintained a strong focus on rigorous cost control measures and strategic outsourcing to minimise fixed overheads, while advancing our research and development efforts," says Chief Executive Officer & Chair Tim McCarthy. "These initiatives are aligned with our preparation for upcoming patent filings this year. Furthermore, we strengthened the balance sheet and extended our cash runway through the successful completion of an oversubscribed placing in February 2025." The firm adds it remains focused on bringing its two key late-stage clinical assets, P140 for systemic lupus erythematosus and chronic inflammatory demyelinating polyneuropathy, closer to the market, and on securing further partnership deals for P140 together with its earlier stage assets.

"These initiatives are aligned with our preparation for upcoming patent filings this year.s. Furthermore, we strengthened the balance sheet and extended our cash runway through the successful completion of an oversubscribed placing in February 2025."

By year end???

Where are you????????

£6.32

Retail Offer!